ArticleFrontiers in medicine2023
Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics.
Huan Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.